The China Sci-Tech Innovation Gala, a national science and technology event produced by China Media Group (CMG), was broadcast in prime time on CCTV-1 and CCTV-10 on October 30.

Toumai® Demonstrates Intercontinental Remote Operation Capability
At the Gala, CMG host Tengyue Zhang performed a remarkable live demonstration — operating the Toumai® Surgical Robot from Beijing to delicately pick pollen with a robotic arm located 12,000 kilometers away in Luanda, Angola.
The operation was executed with smooth control, near-zero latency, and ultra-clear visuals, showcasing Toumai®’s powerful performance in long-distance signal transmission, real-time precision control, and millimeter-level accuracy — leaving the audience in awe.

This intercontinental demonstration symbolizes how technology is bridging medical distances and helping to redefine the future of global telesurgery.
Crossing 3,000 Kilometers to Challenge “the King of Cancers”
During the same program, Professor Rong Liu, a leading hepatobiliary and pancreatic surgeon, successfully performed a pancreatic tumor resection on a patient in Xinjiang — 3,000 kilometers away — using the Toumai® Surgical Robot from Beijing.

The entire procedure was completed in just 108 minutes with minimal blood loss, and the patient was able to get out of bed the very next day.
Professor Liu said, “With the Toumai® Surgical Robot, we’ve broken through spatial limits — allowing top experts to operate across great distances and enabling patients in remote areas to receive world-class treatment locally.”
He added that remote surgical systems not only enable real-time expert guidance and teaching, but also significantly enhance surgical training efficiency, paving new paths for talent cultivation and technology dissemination in complex surgery.
Empowering Medicine Through Innovation, Sharing Wisdom for Humanity
Dr. Chao He, President of MicroPort® MedBot™, was invited to speak at the event, where he shared the company’s vision and progress in product innovation, remote technology, and global expansion.

“We are using technology to empower surgeons worldwide — helping more doctors gain access to advanced training sooner, and allowing more patients to benefit earlier. Our goal is to make surgery easier, safer, and more accessible for everyone,” said Dr. He.
On CMG’s grand stage, Toumai® not only demonstrated the excellence of a world-class surgical robot, but also represented China’s confidence and commitment to the future of medicine.
To date, Toumai® has obtained market access in over 60 countries and achieved commercial deployment in nearly 40, with its telesurgery system approved in multiple regions. These milestones lay a solid foundation for telesurgery, online mentoring, and cross-border medical collaboration.
-
2025-11-14Toumai® Robotic Fluorescence Imaging System Receives EU CE Certification -
2025-10-13Toumai® Robot Assists in Complex Pancreaticoduodenectomy with SMV Resection and Prosthetic Graft Reconstruction -
2025-10-09Toumai® Surgical Robot Achieves Global Commercialization Milestone with 100 Orders






Hu ICP Bei No. 20013662 HGWA Bei No. 31011502015178
" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd.” . They have been authorized to be used by Shanghai Microport Medbot (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.
